{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2015, Part 3

Purpose of Activity

To provide an overview of nine new drugs recently approved by the FDA.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. List indications for nine new drugs.
  2. List contraindications for nine new drugs.
  3. Identify nursing considerations related to these new drugs.
Price: $24.95

Credits:

  • ANCC 2.5 CH / 2.5 APH
  • DC - BON 2.5 CH
  • FL - BON 2.5 CH
  • GA - BON 2.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.

Awarded Advanced Pharmacology Hours







Test Code: N1015A
Published: Oct 2015
Expires: 9/4/2020
Sources: Nursing2020
Passing Score: 13/18 (72%)
Authors: Daniel A. Hussar, PhD